Towards Formulation of Highly Acidic Active Ingredients: Development of Clinically Effective Concentrated Trichloroacetic Acid Gel for Wart Management

Helmy, Abdelrahman M.; Ahmed, Shimaa; Sabaa, Ramy M. El; Abdel-Wahab, Hossam; Abouelmagd, Sara A.

doi:10.1208/s12249-023-02615-7

Cited by 3 publications

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The stretching vibration of the pyranose ring's (C-H) bond that characterizes the polysaccharides is seen at 2861 cm − 1 . The spectrum also shows a further three peaks at 1666, 1594 and 1096 cm − 1 indicating the stretching vibration of the amidic (C = O) group, the bending vibration of the primary amine (N-H) group and the asymmetric stretching vibration of the (C-O-C) bridge, respectively [40,41]. The PVA spectrum demonstrates the broad stretching vibration band of the (-OH) bond at the range of 3000-3700 cm -1 and the sharp stretching vibration band of the aliphatic (C-H) bond at 2920 cm -1 .…”

Section: Ft-ir Studiesmentioning

confidence: 99%

Rosuvastatin-laden Nanofibrous Patches for Effective Treatment of Corneal Ulcer in Experimental Animals

Helmy,

Hamed,

Abdelghany

et al. 2023

Preprint

Self Cite

View full text Add to dashboard Cite

Corneal ulceration is a "silent epidemic" that impacts laborers’ lives, particularly in low-income countries, and calls for a unique ophthalmic drug delivery strategy that overcomes ocular barriers to promptly achieve therapeutic outcomes while remaining cost-effective. Rosuvastatin, a third-generation statin that significantly accelerates tissue regeneration and wound healing, could be proposed as a potential treatment for corneal ulcers. Based on these pillars, the current study aims to develop a nanofibers-based corneal patch laden with rosuvastatin, for the first time, as a novel approach for the treatment of corneal ulcers. Several characterizations were performed for the rosuvastatin-laden nanofibers (e.g., drug encapsulation efficiency, drug loading capacity, morphological analysis, elemental mapping, compatibility with other ingredients, and in vitro release studies) indicating the nanofibers' feasibility for the stated purpose. The therapeutic effects of rosuvastatin-laden nanofibers were examined on a surgically generated corneal ulcer rabbit model. The treatment outcomes were evaluated both macroscopically (e.g., corneal opacity degree and area of ulceration) and histologically demonstrating that the rosuvastatin-laden nanofibers heal corneal ulcers promptly. In light of this, the study emphasizes that rosuvastatin has a significant potential for healing corneal ulcers and that fast-release nanofibers may be an ideal drug delivery platform for treating corneal diseases topically.

show abstract

Section: Ft-ir Studiesmentioning

confidence: 99%